These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 17179019)

  • 1. Prospective familial assessment in dilated cardiomyopathy: cardiac autoantibodies predict disease development in asymptomatic relatives.
    Caforio AL; Mahon NG; Baig MK; Tona F; Murphy RT; Elliott PM; McKenna WJ
    Circulation; 2007 Jan; 115(1):76-83. PubMed ID: 17179019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical implications of anti-heart autoantibodies in myocarditis and dilated cardiomyopathy.
    Caforio AL; Tona F; Bottaro S; Vinci A; Dequal G; Daliento L; Thiene G; Iliceto S
    Autoimmunity; 2008 Feb; 41(1):35-45. PubMed ID: 18176863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammatory dilated cardiomyopathy (DCMI).
    Maisch B; Richter A; Sandmöller A; Portig I; Pankuweit S;
    Herz; 2005 Sep; 30(6):535-44. PubMed ID: 16170686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-heart autoantibodies in familial dilated cardiomyopathy.
    Caforio AL; Vinci A; Iliceto S
    Autoimmunity; 2008 Sep; 41(6):462-9. PubMed ID: 18781472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of left ventricular enlargement as a marker of early disease in familial dilated cardiomyopathy.
    Fatkin D; Yeoh T; Hayward CS; Benson V; Sheu A; Richmond Z; Feneley MP; Keogh AM; Macdonald PS
    Circ Cardiovasc Genet; 2011 Aug; 4(4):342-8. PubMed ID: 21636824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Echocardiographic evaluation in asymptomatic relatives of patients with dilated cardiomyopathy reveals preclinical disease.
    Mahon NG; Murphy RT; MacRae CA; Caforio AL; Elliott PM; McKenna WJ
    Ann Intern Med; 2005 Jul; 143(2):108-15. PubMed ID: 16027452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stimulating autoantibodies directed against the cardiac beta1-adrenergic receptor predict increased mortality in idiopathic cardiomyopathy.
    Störk S; Boivin V; Horf R; Hein L; Lohse MJ; Angermann CE; Jahns R
    Am Heart J; 2006 Oct; 152(4):697-704. PubMed ID: 16996841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance of troponin I efflux and troponin autoantibodies in patients with dilated cardiomyopathy.
    Miettinen KH; Eriksson S; Magga J; Tuomainen P; Kuusisto J; Vanninen EJ; Turpeinen A; Punnonen KR; Pettersson K; Peuhkurinen KJ
    J Card Fail; 2008 Aug; 14(6):481-8. PubMed ID: 18672196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significance of dyslipidaemia in patients with heart failure of unexplained aetiology.
    Skwarek M; Bilińska ZT; Mazurkiewicz Ł; Grzybowski J; Kruk M; Kurjata P; Piotrowski W; Ruzyłło W
    Kardiol Pol; 2008 May; 66(5):515-22, discussion 523-4. PubMed ID: 18537059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The natural history of dilated cardiomyopathy: a review of the Heart Muscle Disease Registry of Trieste].
    Di Lenarda A; Pinamonti B; Mestroni L; Salvi A; Sabbadini G; Gregori D; Perkan A; Zecchin M; Carniel E; Bussani R; Silvestri F; Morgera T; Camerini F; Sinagra G;
    Ital Heart J Suppl; 2004 Apr; 5(4):253-66. PubMed ID: 15346692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Familial dilated cardiomyopathy: cardiac abnormalities are common in asymptomatic relatives and may represent early disease.
    Baig MK; Goldman JH; Caforio AL; Coonar AS; Keeling PJ; McKenna WJ
    J Am Coll Cardiol; 1998 Jan; 31(1):195-201. PubMed ID: 9426040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of troponin I-autoantibodies in chronic dilated and ischemic cardiomyopathy.
    Doesch AO; Mueller S; Nelles M; Konstandin M; Celik S; Frankenstein L; Goeser S; Kaya Z; Koch A; Zugck C; Katus HA
    Basic Res Cardiol; 2011 Jan; 106(1):25-35. PubMed ID: 20957484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic predictors and remodeling of dilated cardiomyopathy in muscular dystrophy.
    Jefferies JL; Eidem BW; Belmont JW; Craigen WJ; Ware SM; Fernbach SD; Neish SR; Smith EO; Towbin JA
    Circulation; 2005 Nov; 112(18):2799-804. PubMed ID: 16246949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ventricular repolarization dynamicity provides independent prognostic information toward major arrhythmic events in patients with idiopathic dilated cardiomyopathy.
    Iacoviello M; Forleo C; Guida P; Romito R; Sorgente A; Sorrentino S; Catucci S; Mastropasqua F; Pitzalis M
    J Am Coll Cardiol; 2007 Jul; 50(3):225-31. PubMed ID: 17631214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The frequency of familial dilated cardiomyopathy in a series of patients with idiopathic dilated cardiomyopathy.
    Michels VV; Moll PP; Miller FA; Tajik AJ; Chu JS; Driscoll DJ; Burnett JC; Rodeheffer RJ; Chesebro JH; Tazelaar HD
    N Engl J Med; 1992 Jan; 326(2):77-82. PubMed ID: 1727235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Dilated cardiomyopathy: etiology, clinical criteria for diagnosis and screening of the familial form].
    Startari U; Taylor MR; Sinagra G; Di Lenarda A; Mestroni L
    Ital Heart J Suppl; 2002 Apr; 3(4):378-85. PubMed ID: 12025380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term outcome and risk stratification in dilated cardiolaminopathies.
    Pasotti M; Klersy C; Pilotto A; Marziliano N; Rapezzi C; Serio A; Mannarino S; Gambarin F; Favalli V; Grasso M; Agozzino M; Campana C; Gavazzi A; Febo O; Marini M; Landolina M; Mortara A; Piccolo G; Viganò M; Tavazzi L; Arbustini E
    J Am Coll Cardiol; 2008 Oct; 52(15):1250-60. PubMed ID: 18926329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy.
    Assomull RG; Prasad SK; Lyne J; Smith G; Burman ED; Khan M; Sheppard MN; Poole-Wilson PA; Pennell DJ
    J Am Coll Cardiol; 2006 Nov; 48(10):1977-85. PubMed ID: 17112987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum matrix metalloproteinase-3 as a novel marker for risk stratification of patients with nonischemic dilated cardiomyopathy.
    Ohtsuka T; Nishimura K; Kurata A; Ogimoto A; Okayama H; Higaki J
    J Card Fail; 2007 Nov; 13(9):752-8. PubMed ID: 17996824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of protein A immunoadsorption in patients with advanced chronic dilated cardiomyopathy.
    Doesch AO; Konstandin M; Celik S; Kristen A; Frankenstein L; Hardt S; Goeser S; Kaya Z; Katus HA; Dengler TJ
    J Clin Apher; 2009; 24(4):141-9. PubMed ID: 19591221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.